The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

Active, not recruiting

• Conditions: Parkinson's Disease
• Interventions: Other: There is no intervention, this is a biorepository.

• Registration Number: NCT00766948
• Lead Sponsor: Scripps Translational Science Institute

Brief Summary

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-08
• Study First Submitted: 2008-10-02
• Study First Submitted QC: 2008-10-02
• Study First Posted: 2008-10-06
• Status Verified: 2025-01
• Last Update Submitted: 2025-01-15
• Last Update Posted: 2025-01-16
• Primary Completion: 2030-08
• Study Completion: 2030-08

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Is age 30 years or older at the time of onset of Parkinson's
• Has been diagnosed with idiopathic Parkinson's Disease by a Scripps Neurologist
• Is reliable, cooperative and willing to comply with all protocol-specified procedures and/or sub-study if consented or have legal representative/guardian willing to do so
• Able to understand and grant informed consent or have a legal representative/ guardian who is able to do so

Exclusion Criteria

• Patient has been previously enrolled in The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
• If a blood draw would be contraindicated for any reason
• Has a significant chronic medical condition (i.e. CVA, hepatic encephalopathy) which, in the investigator's option, may interfere with the patient's optimal participation in the study
• Treatment with any investigational agents or devices within 30 days preceding enrollment in the study
• Has undergone ECT within 90 days preceding enrollment in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
No Treatment	There is no intervention, this is a biorepository.	-

Primary Outcome Measures

Name	Time	Method
Neurogenetic databank	Study completion	initiate a Parkinson's disease neurogenetic databank by obtaining blood samples in order to define genes for Parkinson's disease and other neurological conditions.

Trial Locations

Locations (3)

Scripps Clinic, Torrey Pines; 🇺🇸 La Jolla, California, United States

Scripps Translational Science Institute; 🇺🇸 La Jolla, California, United States

The Scripps Research Institute; 🇺🇸 La Jolla, California, United States